368 related articles for article (PubMed ID: 17492949)
1. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol.
Qureshi AC; Bahri A; Breen LA; Barnes SC; Powrie JK; Thomas SM; Carroll PV
Clin Endocrinol (Oxf); 2007 May; 66(5):632-5. PubMed ID: 17492949
[TBL] [Abstract][Full Text] [Related]
2. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test.
Marcus-Perlman Y; Tordjman K; Greenman Y; Limor R; Shenkerman G; Osher E; Stern N
Clin Endocrinol (Oxf); 2006 Feb; 64(2):215-8. PubMed ID: 16430723
[TBL] [Abstract][Full Text] [Related]
3. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic--pituitary--adrenal axis activity.
Gozansky WS; Lynn JS; Laudenslager ML; Kohrt WM
Clin Endocrinol (Oxf); 2005 Sep; 63(3):336-41. PubMed ID: 16117823
[TBL] [Abstract][Full Text] [Related]
4. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
5. The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test.
Nickelsen T; Lissner W; Schöffling K
Exp Clin Endocrinol; 1989; 94(3):275-80. PubMed ID: 2560985
[TBL] [Abstract][Full Text] [Related]
6. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women.
Shifren JL; Desindes S; McIlwain M; Doros G; Mazer NA
Menopause; 2007; 14(6):985-94. PubMed ID: 17507833
[TBL] [Abstract][Full Text] [Related]
7. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
[TBL] [Abstract][Full Text] [Related]
8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
9. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
10. Effects of high dose oestrogen therapy on circulating inflammatory markers.
Wilson R; Spiers A; Ewan J; Johnson P; Jenkins C; Carr S
Maturitas; 2009 Mar; 62(3):281-6. PubMed ID: 19231116
[TBL] [Abstract][Full Text] [Related]
11. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
Prázný M; Fait T; Vrablik M
Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
[TBL] [Abstract][Full Text] [Related]
12. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G; Ozmen B; Erguder I
Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
[TBL] [Abstract][Full Text] [Related]
13. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
14. [Hormone replacement therapy with transdermal estradiol lowers insulin-cortisol and lipoproteins levels in postmenopausal women].
Basurto L; Saucedo R; Ochoa R; Hernández M; Zárate A
Ginecol Obstet Mex; 2002 Oct; 70():491-5. PubMed ID: 12557803
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid-binding globulin affects the relationship between circulating adiponectin and cortisol in men and women.
Fernandez-Real JM; Pugeat M; López-Bermejo A; Bornet H; Ricart W
Metabolism; 2005 May; 54(5):584-9. PubMed ID: 15877287
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of the short Synacthen test in the presence of low cortisol-binding globulin: two case reports.
Moisey R; Wright D; Aye M; Murphy E; Peacey SR
Ann Clin Biochem; 2006 Sep; 43(Pt 5):416-9. PubMed ID: 17022886
[TBL] [Abstract][Full Text] [Related]
17. Measurement of salivary cortisol with liquid chromatography-tandem mass spectrometry in patients undergoing dynamic endocrine testing.
Perogamvros I; Owen LJ; Keevil BG; Brabant G; Trainer PJ
Clin Endocrinol (Oxf); 2010 Jan; 72(1):17-21. PubMed ID: 19302583
[TBL] [Abstract][Full Text] [Related]
18. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma.
Beishuizen A; Thijs LG; Vermes I
Intensive Care Med; 2001 Oct; 27(10):1584-91. PubMed ID: 11685298
[TBL] [Abstract][Full Text] [Related]
19. Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon?
Manco M; Fernández-Real JM; Valera-Mora ME; Déchaud H; Nanni G; Tondolo V; Calvani M; Castagneto M; Pugeat M; Mingrone G
Diabetes Care; 2007 Jun; 30(6):1494-500. PubMed ID: 17526821
[TBL] [Abstract][Full Text] [Related]
20. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
Bernardi F; Pieri M; Stomati M; Luisi S; Palumbo M; Pluchino N; Ceccarelli C; Genazzani AR
Gynecol Endocrinol; 2003 Feb; 17(1):65-77. PubMed ID: 12724021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
